Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG-K10 in Adult Asthmatic Subjects
NCT05382910Phase 2Unknown
- Sponsor
- Hunan Mabgeek Biotechnology
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of comekibart in asthma, sponsored by Hunan Mabgeek Biotechnology. Status: unknown.
02
Drugs
comekibart
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05382910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05382910.